Skip to main content
SpringerLink
Log in

DNA-based immunization against hepatitis B virus

  • Chapter
Gene Vaccination: Theory and Practice

Part of the book series: Principles and Practice ((PRINCIPLES))

Abstract

Hepatitis B virus (HBV) poses a widespread and serious international health problem that is not completely managed by the current vaccines due to issues of availability, affordability and their effectiveness in inducing the appropriate immune responses. This is especially true with respect to chronic carriers of HBV for whom a cellular immune response, not achieved with the current vaccines, is required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Alberti A, Cavalletto D, Pontisso P, Chemello L, Tagariello G, Belussi F (1988) Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 25: 1421

    Article  Google Scholar 

  2. Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230: 1160

    Article  PubMed  CAS  Google Scholar 

  3. Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hilleman MR (1976) Development and chimpanzee testing of a vaccine against human hepatitis B. Proc Soc Exp Biol Med 151: 694

    PubMed  CAS  Google Scholar 

  4. Coates RA, Halliday ML, Rankin JG, Stewart JD, Bristow NJ, Granero R, West DJ (1988) Immunogenicity and safety of a yeast-derived recombinant DNA hepatitis B vaccine in health care workers. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1038–1042

    Google Scholar 

  5. Centers for Disease Control (1987) Recommendations of the Immunization Practises Advisory Committee Update on hepatitis B prevention. MMWR 36: 353

    Google Scholar 

  6. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG (1993) Plasmid DNA is superior to viral vectors for direct gene transfer in adult mouse skeletal muscle. Hum Gene Ther 4: 733

    Article  PubMed  CAS  Google Scholar 

  7. Davis HL, Michel M-L, Whalen RG (1993) DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genet 2: 1847

    Article  PubMed  CAS  Google Scholar 

  8. Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG (1994) Direct gene transfer in muscle with plasmid DNA for the purpose of nucleic acid immunization. Vaccine 12: 1503

    Article  PubMed  CAS  Google Scholar 

  9. Davis HL, Schirmbeck R, Reimann J, Whalen RG (1995) DNA-mediated immunization in mice induces a potent MHC class-I restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 6: 1447

    Article  PubMed  CAS  Google Scholar 

  10. Davis HL, Mancini M, Michel M-L, Whalen RG (1996) DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14: 910

    Article  PubMed  CAS  Google Scholar 

  11. Davis HL, McCluskie MJ, Gerin JL, Purcell RH (1996) DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93: 7213

    Article  PubMed  CAS  Google Scholar 

  12. Davis HL, Brazolot Milian CL, Watkins SC (1997) Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 4: 181

    Article  PubMed  CAS  Google Scholar 

  13. Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56: 651

    Article  PubMed  CAS  Google Scholar 

  14. Gerety RI (1988) Recombinant hepatitis B vaccines. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1017–1024

    Google Scholar 

  15. Gerin JL, Purcell RH, Lerner RA (1985) Use of synthetic peptides to identify protective epitopes of the heptitis B surface antigen. Vaccines 85. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 235–239

    Google Scholar 

  16. Gerlich WH, Bruss V (1993) Functions of hepatitis B virus proteins and molecular targets for protective immunity. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 41–82

    Google Scholar 

  17. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 91: 3764

    Article  PubMed  CAS  Google Scholar 

  18. Hadler SC. Margolis HS (1993) Epidemiology of hepatitis B virus infection. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 141–158

    Google Scholar 

  19. Hibberd PL, Rubin RH, Dienstag JL (1993) Needs unfulfilled by current hepatitis B vaccines. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 323–336

    Google Scholar 

  20. Hilleman MR (1993) Plasma-derived hepatitis B vaccine: a breakthrough in preventive medicine. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 17–40

    Google Scholar 

  21. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M (1986) A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83: 9174

    Article  PubMed  CAS  Google Scholar 

  22. Iwarson S, Tabor E, Thomas HC, Snoy P, Gerety RJ (1985) Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology 88: 763

    PubMed  CAS  Google Scholar 

  23. Kane MA (1993) Global control of hepatitis B through universal infant immunization. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 309–322

    Google Scholar 

  24. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546

    Article  PubMed  CAS  Google Scholar 

  25. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D (1992) The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 175: 495

    Article  PubMed  CAS  Google Scholar 

  26. Lubeck MD, Davis AR, Chengalvala M, Natuk RJ, Morin JE, Molnar-Kimber K, Mason BB, Bhat BM, Mizutani S, Hung PP, Purcell RH (1989) Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 86: 6763

    Article  PubMed  CAS  Google Scholar 

  27. Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel M-L (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing “nonresponse” to HBsAg. J Med Virol 39: 67

    Article  PubMed  CAS  Google Scholar 

  28. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L (1996) DNA-mediated immunization breaks tolerance in a transgenic mouse model of hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 93: 12496

    Article  PubMed  CAS  Google Scholar 

  29. Maugh TH (1980) Hepatitis B vaccine passes first major test. Science 210: 760

    Article  PubMed  Google Scholar 

  30. Maupas P, Goudeau A, Coursaget P, Drucker J (1976) Immunization against hepatitis B in man. Lancet 1: 1367

    Article  PubMed  CAS  Google Scholar 

  31. Michel M-L, Pontisso P, Sobczak E, Malpièce Y, Streeck RE, Tiollais P (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Nati Acad Sci USA 81: 7708

    Article  CAS  Google Scholar 

  32. Michel M-L, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92: 5307

    Article  PubMed  CAS  Google Scholar 

  33. Milich DR (1988) T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 9: 380

    Article  PubMed  CAS  Google Scholar 

  34. Moss B, Smith GL, Gerin JL, Purcell RH (1984) Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311: 67

    Article  PubMed  CAS  Google Scholar 

  35. Murray K, Bruce SA, Hinnen A, Wingfield P, Erd PMCA van, Reus A de, Schellekens H (1984) Hepatitis B virus antigens made in microbial cells immunize against viral infection. EMBO J 3: 645

    PubMed  CAS  Google Scholar 

  36. Neurath AR, Kent SBH, Strick N, Taylor P, Stevens CE (1985) Hepatitis B virus contains pre-S gene-encoded domains. Nature 315: 154

    Article  PubMed  CAS  Google Scholar 

  37. Neurath AR, Kent SBH, Parker K, Prince AM, Strick N, Brotman B, Sproul P (1986) Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4: 35

    Article  PubMed  CAS  Google Scholar 

  38. Prince AM (1981) The use of chimpanzees in biomedical research. US Department of Health and Human Services: Trends in bioassay methodology in vivo, in vitro and mathematical approaches. NIH publication no. 82–2382. NIH, Bethesda, pp 81–98

    Google Scholar 

  39. Prince AM, Whalen RG, Brotman B (1997) Successful nucleic acid based immunization of newborn chimpanzees against HBV. Vaccine 15: 916

    Article  PubMed  CAS  Google Scholar 

  40. Purcell RH, Gerin JL (1975) Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci 270: 395

    Article  PubMed  CAS  Google Scholar 

  41. Purcell RH, Gerin JL (1987) Hepatitis B vaccines past present and future: lessons for AIDS vaccine development. In: Robinson W, Koike K, Will H (eds) Hepadna viruses. Liss, New York, pp 465–479

    Google Scholar 

  42. Reesink-Brongers EE, Reesink HW, Brummelhuis HGJ, Schut BJT, Dees PJ, Lelie PN, Raap AK, Wilsonde Stürler LA, Aken WG van, Balner H, Eerd PMCA van, Schie TC van, Stitz LW, Steenis B van, Feltkamp-Vroom TM (1982) Preparation and evaluation of heat-inactivated HBsAg as a vaccine against hepatitis B. In: Szmuness W, Alter HJ, Maynard JE (eds) Viral Hepatitis 1981 International Symposium. The Franklin Institute Press, Philadelphia, pp 437–450

    Google Scholar 

  43. Ridge JP, Fuchs EJ, Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271: 1723

    Article  PubMed  CAS  Google Scholar 

  44. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman GJ, Lotz M, Carson DA, Raz E (1996) lmmunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 353

    Article  Google Scholar 

  45. Schirmbeck R, Melber K, Kuhröber A, Janowicz ZA, Reimann J (1994) Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8’ cytotoxic T lymphocyte responses in vivo. J Immunol 152: 1110

    PubMed  CAS  Google Scholar 

  46. Stephenne J (1988) Recombinant versus plasma-derived hepatitis B vaccines: issues of safety immunogenicity and cost-effectiveness. Vaccine 6: 299

    Article  PubMed  CAS  Google Scholar 

  47. Tang D, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152

    Article  PubMed  CAS  Google Scholar 

  48. Thornton GB, Milich DR, Chisari F, Mitamura K, Kent SB, Neurath R, Purcell RH, Gerin JL (1987) Immune response in primates to the pre-S2 region of hepatitis B surface antigen: identification of a protective determinant. In: Chanock RM, Lerner RA, Brown F, Ginsberg H (eds) Vaccines 87. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 77–80

    Google Scholar 

  49. Tiollais P, Buendia M-A (1991) Hepatitis B virus. Sci Am 264: 48

    Article  Google Scholar 

  50. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347

    Article  PubMed  CAS  Google Scholar 

  51. Wolff JA, Malone RW, Williams P, Chong W, Ascadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465

    Article  PubMed  CAS  Google Scholar 

  52. Yano M, Tashiro A (1988) Clinical evaluation of recombinant yeast-derived hepatitis B vaccine. In Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1050–1052

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Loeb Research Institute, Ottawa Civic Hospital, 1053 Carling Avenue, K1Y 4E9, Ottawa, Canada

    Heather L. Davis & Cynthia L. Brazolot Millan

  2. Faculties of Health Sciences & Medicine, University of Ottawa, Ottawa, Canada

    Heather L. Davis

Authors
  1. Heather L. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia L. Brazolot Millan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of California, San Diego, 9500 Gilman Drive, 92093-0663, La Jolla, CA, USA

    Eyal Raz M.D. (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Davis, H.L., Brazolot Millan, C.L. (1998). DNA-based immunization against hepatitis B virus. In: Raz, E. (eds) Gene Vaccination: Theory and Practice. Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46867-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-46867-4_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-46869-8

  • Online ISBN: 978-3-642-46867-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation